Company Filing History:
Years Active: 2025
Title: Marina Kovaleva: Innovator in Antigen Binding Molecules
Introduction
Marina Kovaleva is a distinguished inventor based in Craigavon, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding molecules. Her work focuses on innovative solutions that have the potential to impact therapeutic applications.
Latest Patents
Marina holds a patent for ROR1-specific antigen binding molecules. The present invention relates to receptor tyrosine kinase-like orphan receptor 1 (ROR1) specific antigen binding molecules and associated fusion proteins and conjugates. Additionally, the invention includes conjugated immunoglobulin-like shark variable novel antigen receptors (VNARs). This patent showcases her expertise and commitment to advancing medical science.
Career Highlights
Marina is currently employed at Almac Discovery Limited, where she continues to push the boundaries of research and innovation. Her role at the company allows her to collaborate with other talented professionals in the field.
Collaborations
Some of her notable coworkers include Estelle Grace McLean and Paul Richard Trumper. Their collective efforts contribute to the success of their projects and the advancement of their research initiatives.
Conclusion
Marina Kovaleva is a remarkable inventor whose work in antigen binding molecules exemplifies innovation in biotechnology. Her contributions are paving the way for future advancements in therapeutic applications.